Selection of intravascular contrast media in clinical radiology.
From previous experimental investigations and from the present clinical experience in more than 2000 examinations it is clear that the adverse reactions of Omnipaque are markedly less when compared with those of conventional contrast media for intravascular use. Similar observations have been made for other low osmolar contrast media. These new media should therefore replace the conventional media for intravascular use. The economical consequences are discussed.
D002986:Clinical Trials as Topic; D003287:Contrast Media / Q000008:administration & dosage / Q000633:toxicity*; D003362:Cost-Benefit Analysis; D004361:Drug Tolerance; D006801:Humans; D007275:Injections, Intravenous; D007463:Iodobenzoates / Q000633:toxicity*; D007472:Iohexol; D008793:Metrizamide / Q000633:toxicity; D009994:Osmolar Concentration; D014283:Triiodobenzoic Acids / Q000008:administration & dosage / Q000633:toxicity*; D014783:Viscosity
D003287:Contrast Media; D007463:Iodobenzoates; D014283:Triiodobenzoic Acids; D007472:Iohexol; D008793:Metrizamide